|
|
1980 |
Dottore di Medicina |
1984 |
Diplomat American Board of Internal Medicine |
1987 |
Diplomat American Board of Pulmonary Medicine |
1988 |
Fellow American College of Chest Physicians |
| |
|
|
|
1980 |
New Jersey |
1983 |
New York |
| |
|
|
|
1985 - Present |
Christ Hospital — Jersey City, New Jersey 07306 |
2005 - Present |
Palisades Medical Center — 7600 River Road, NB, NJ 07047 |
1985 - 2003 |
Meadowlands Hospital — Secaucus, New Jersey 07094 |
1985 - 1988 |
St. Francis Hospital — 25 McWilliams Place, Jersey City, New Jersey 07302 |
1985 - 1997 |
Greenville Hospital — 1825 Kennedy Blvd., Jersey City, New Jersey 07304 |
1998 - 2000 |
Jersey City Medical Center — Jersey City, New Jersey 07305 |
| |
|
|
|
1987 - 1990 |
Co-Director Pulmonary Medicine — Christ Hospital, Jersey City, New Jersey |
1988 - 1991 |
Disaster Committee — Christ Hospital, Jersey City, New Jersey |
1988 - 1990 |
ICU Committee — Christ Hospital, Jersey City, New Jersey |
1990 - 1993 |
Pharmacy Committee — Christ Hospital, Jersey City, New Jersey |
1991 - 1995 |
Critical Care Committee — St. Francis Hospital, Jersey City, New Jersey |
1992 - 1995 |
Credential Committee — Christ Hospital, Jersey City, New Jersey |
1993 - 1995 |
Director of Pulmonary Medicine — St. Francis Hospital, Jersey City, New Jersey |
1996 - 2000 |
Medical Director — Pavonia Medical Associates, Jersey City, North Bergen - Secaucus,
New Jersey |
1998 - 2003 |
Director Clinical Research — Jersey Integrated Health, Jersey City - North Bergen - Secaucus,
New Jersey |
| |
|
|
|
1973 |
B.S., Jersey City State College, New Jersey |
1981 |
M.D., University of Messina, Messina, Italy |
| |
|
|
|
1980 - 1981 |
Internship (PGY-1) Medicine — Mountainside Hospital, Montclair, New Jersey |
1981 - 1983 |
Residency (PGY-2, PGY-3) Medicine — St. Michael’s Hospital, Newark, New Jersey |
1983 - 1985 |
Fellowship (PGY-4, PGY-5) Pulmonary Medicine — New York Medical College,
Westchester Medical Center, Valhalla, New York |
| |
|
|
|
1994 |
Ventilator Management — Christ Hospital, Jersey City, New Jersey |
1995 |
COPD Update — St. Francis Hospital, Jersey City, New Jersey |
1996 |
Lung Reduction Surgery — St. Francis Hospital, Jersey City, New Jersey |
1997 |
Antibiotics in the Critical Care Setting — Greenville Hospital, Jersey City, New Jersey |
2001- 02 |
High Frequency Chest Wall Oscillating Vest/COPD — Scottsdale, Arizona; Hilton Head,
South Carolina |
2001 |
ACCP Meeting — Smoking Cessation and Practice Revenues, San Francisco, California |
2002 |
New York State Thoracic Society — Smoking Cessation, West Point, New York |
2004 |
CME Lecture — Evidence-Based Smoking Cessation Protocols, Christ Hospital, New Jersey |
2004 |
CME Lecture — Compliance with Federal Guidelines in the Treatment of Tobacco Addiction, Palisade Medical Centre, North Bergen, NJ |
2005 |
Lecture Series — Current Trends in Asthma Therapy, Schering Plough |
| |
|
|
|
1997 |
ABC News and World Report — Smoking Cessation |
1998 |
CBS Evening News with Dan Rather — Smoking Cessation |
1999 |
NBC Today Show — I Quit Smoking Cessation Program |
2001 |
COPD Satellite Media Tour — Sponsored by Novartis, November 13 |
2001 |
Video News Release COPD/FORADIL — Sponsored by Novartis |
2005 |
Chairperson, Inauguration Ceromony — I Quit Smoking Clinic, Palisade Medical Center, NB, NJ. Key note speaker US Senator Frank Lautenberg (D-NJ). |
| |
|
|
|
|
Advanced Respiratory (Vest) |
|
Transworld Health |
2001 - 2003 |
Therapro |
2005 - 2006 |
Wyeth Laboratories |
2005 - 2006 |
Palisade General Medical Center |
| |
|
|
|
Principal Investigator
(See Appendix A)
Appendix A
Clinical Research |
|
| |
|
1999 |
The Effect of Zyban vs. Placebo as an Aid to Smoking Reduction. Sponsored by GlaxoWellcome. |
1999 |
Randomized, Double-Blind, Double-Dummy, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Oral Augmentin SR 2000/125mg Twice Daily for 7 Days Oral Clarithromycin 500mg Twice Daily for 7 Days in the Treatment of Acute Exacerbation of Chronic Bronchitis. Sponsored by Smithkline. |
1999 |
Open, Non-Comparative, Multicenter Study to Assess the Efficacy and Safety of Oral Augmentin SR1750-125mg Twice Daily for 7 or 14 Days for the Treatment of Bacterial Community Acquired Pneumonia in Adults. Sponsored by SmithKline (SB-2500/547) |
2000 |
Multi-Center, Multinational Open Clinical Study to Explore Relationships between Genotypic and Serologic Findings and Phenotypic Manifestations in a Large Cohort of Participants. Sponsored by Genomics Collaborative (99-302/99-303) 2000 |
2000 |
Double-Blind, Randomized, Placebo-Controlled Surveillance Study of Asthma Event Outcomes in Subjects Receiving Either Usual Pharmacotherapy of Asthma or Usual Pharmacotherapy Plus Salmeterol 42 MCG Twice Daily. Sponsored by GlaxoWellcome (SMART) |
2000 |
Short Term Assessment of the Effects of High Frequency Chest Wall Oscillation on the Pulmonary Function and Quality of Life of Patients with COPD. Sponsorsed by American Biosystems, Inc. (ABI VEST) |
2001 |
High Frequency Chest Wall Oscillation in COPD Patients in a 90-Day Study. Sponsored by American Biosystems, Inc. (ABI VEST) |
2001 |
Multicenter, Double-Blind, Randomized Study to Compare The Safety and Efficacy of Levofloxacin 750mg Once Daily for Five Days vs. Levofloxacin 500mg Once Daily for 10 Days in the Treatment of Mild to Severe Community Acquired Pneumonia in Adults. Sponsored by Ortho-McNeil (CAPS 150) |
2001 |
Multicenter, Open-Label, Non-Comparative Study to Evaluate the Safety and Efficacy of Levofloxacin Once Daily for Five Days in the Treatment of Mild to Severe Community-Acquired Pneumonia Adults. (CAPS 171) Sponsored by Ortho-McNeill |
2001 |
Randomized, Blinded Trial Studying the Efficacy and Safety pg High-Dose 750 mg. Short-Course (3-5 days) Levofloxacin Therapy in Uncomplicated and Complicated Acute Bacterial Exacerbation of Chronic Bronchitis. |
2001 |
Prospective, Randomized, Open-Label, Multicenter Comparison of the Efficacy and Safety of Sequential Treatment with Intravenous (IV) Oral (PO) Moxifloxacin +-IV/PO Azithromycin +- IV/PO Metronidazole Followed by Cefuroxime axetil PO +-PO Azithromycin +-PO Metronidazole in Patients with Community or Nursing Home Acquired Pneumonia. |
| |
|
|
|
2003 |
Sepracor Pharmaceuticals
Surveillance of NJ Ground-Zero workers. |
2003 |
Merck Pharmaceuticals
Surveillance of NJ Ground-Zero workers. |
2007 |
Pfizer Pharmaceuticals
CME GRANT, Establish Centers of Excellence in Diagnosing and Treating Tobacco Addiction |
2008 |
Dey Pharmaceuticals
CME GRANT, Outreach Program to Underserved Populations to Treat Tobacco Addiction |
| |
|
|
|
| Guest Panelist |
Guest Panelist: State of the Art Conference Series.
Medical Communications and Delivery of Health Care.
Sponsored by Stevens Institute of Technology, Hoboken, NJ
S. Vincent Grasso, Coordinator |
| 7/11/07 |
Medical Information and Strategies in Healthcare Delivery
Enhancing the Delivery of Healthcare Services to an Aging U.S. Population |
| 9/19/07 |
Enhancing the Efficiency and Effectiveness of Multimodal Messaging within the Delivery of Healthcare. |
| 10/31/07 |
Strategies to Enhance the Management of non Hospital-based asthmatic and COPD patient. |
